Medicare Enrolled

Dr. Stephanie Nahas-Geiger, M.D.

Neurology · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
900 WALNUT ST, Philadelphia, PA 19107
2159552243
Registered in NPPES since 2007
NPI: 1033265004 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nahas-Geiger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nahas-Geiger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nahas-Geiger

Dr. Stephanie Nahas-Geiger is a neurology specialist in Philadelphia, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Nahas-Geiger performed 222 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Nahas-Geiger received a total of $809,169 from 35 pharmaceutical and/or device companies across 1289 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nahas-Geiger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 222 Medicare services $809,169 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
222
Medicare services
Bottom 34% in PA for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
97 $69 $275
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
55 $101 $435
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
29 $88 $190
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
27 $98 $350
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
14 $142 $360
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$809,169
Total received (2018-2024)
Avg $115,596/year across 7 years
Top 1% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
1,289
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$70,776
2023
$103,558
2022
$33,680
2021
$127,645
2020
$206,042
2019
$174,020
2018
$93,448

Payments by company (2024)

ABBVIE INC.
$31,093
Lilly USA, LLC
$15,427
Axsome Therapeutics, Inc.
$6,681
Teva Pharmaceuticals USA, Inc.
$6,032
Lundbeck LLC
$3,694
Amneal Pharmaceuticals LLC
$3,450
PFIZER INC.
$2,534
Tonix Medicines, Inc.
$1,778
Amgen Inc.
$46
Eisai Inc.
$27
Ipsen Biopharmaceuticals, Inc
$13
Top 3 companies account for 75.2% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$231,662
Allergan, Inc.
$140,998
Teva Pharmaceuticals USA, Inc.
$136,170
ABBVIE INC.
$90,304
Amgen Inc.
$80,346
AbbVie Inc.
$28,668
Lundbeck LLC
$26,203
Supernus Pharmaceuticals, Inc.
$16,706
H. Lundbeck A S
$10,625
BioDelivery Sciences International, Inc.
$9,347
Allergan Inc.
$9,073
PFIZER INC.
$7,374
Axsome Therapeutics, Inc.
$6,681
Amneal Pharmaceuticals LLC
$3,554
Novartis Pharmaceuticals Corporation
$3,335
Biohaven Pharmaceuticals, Inc.
$2,754
TONIX PHARMACEUTICALS, INC.
$2,000
Tonix Medicines, Inc.
$1,778
IMPEL PHARMACEUTICALS INC.
$442
Eli Lilly and Company
$291
Biohaven Pharmaceutical Holding Company Ltd.
$241
Promius Pharma LLC
$161
BIOTISSUE HOLDINGS, INC.
$111
Collegium Pharmaceutical, Inc.
$57
Upsher-Smith Laboratories LLC
$55
UPSHER-SMITH LABORATORIES LLC
$36
Biogen, Inc.
$30
Electronic Waveform Lab, Inc.
$29
Ipsen Biopharmaceuticals, Inc
$27
Eisai Inc.
$27
IDORSIA PHARMACEUTICALS US INC
$23
Avanir Pharmaceuticals, Inc.
$18
Impax Laboratories, Inc.
$14
Currax Pharmaceuticals LLC
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Top 3 companies account for 62.9% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AUSTEDO · Aimovig · Austedo XR · BOTOX · BOTOX - NEUROLOGY · BOTOX COSMETIC · BOTOX THERAPEUTIC · COMIRNATY · Cambia · Dysport · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · Leqembi · NUEDEXTA · NURTEC ODT · ONZETRA XSAIL · PROKERA · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · REYVOW · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · VYEPTI · ZAVZPRET · ZEMBRACE SYMTOUCH · ZOMIG · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Philadelphia?
Compare neurologists in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
516
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nahas-Geiger is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nahas-Geiger experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Nahas-Geiger performed 97 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nahas-Geiger receive payments from pharmaceutical companies?
Yes. Dr. Nahas-Geiger received a total of $809,169 from 35 companies across 1,289 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nahas-Geiger's costs compare to other neurologists in Philadelphia?
Dr. Nahas-Geiger's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nahas-Geiger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →